Retraction. Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer. J Clin Oncol 25:4350–7, 2007.
Publication
, Other
Published in: J Clin Oncol
December 10, 2010
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Clin Oncol
DOI
EISSN
1527-7755
Publication Date
December 10, 2010
Volume
28
Issue
35
Start / End Page
5229
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Retraction. Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer. J Clin Oncol 25:4350–7, 2007. (2010). J Clin Oncol. United States. https://doi.org/10.1200/JCO.2010.33.7311
“Retraction. Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer. J Clin Oncol 25:4350–7, 2007.” J Clin Oncol, December 10, 2010. https://doi.org/10.1200/JCO.2010.33.7311.
“Retraction. Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer. J Clin Oncol 25:4350–7, 2007.” J Clin Oncol, vol. 28, no. 35, 10 Dec. 2010, p. 5229. Pubmed, doi:10.1200/JCO.2010.33.7311.
Published In
J Clin Oncol
DOI
EISSN
1527-7755
Publication Date
December 10, 2010
Volume
28
Issue
35
Start / End Page
5229
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences